유한양행우
65,200KRWMarket close of 10/28 (Wed)
Flat 0.00%0KRWMarket close of 10/28 (Wed)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/29 (Thu)63,700KRWDown -2.30%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 65,200
- High
- 67,200
- Low
- 65,200
- Day range
- Day range low 65,200 high 67,200, open 65,200, close 65,200, previous close 65,200
- Volume
- 0×10K shares
- 66.01 million KRW 0.95× the 20-session average
Market close of 10/28 (Wed)
Where it sits in the 1-year range
15%15% of the way up from the lowest close in 1 year (252 sessions) · -42.5% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range0.00%0.00%, 0.0× the usual (20-session average ±1.79%)That day 0.00% · usual ±1.79% · large-move threshold ±3.6%
The other 2 are within the usual range
- Trading value0.9×usual range
- EarningsOperating income, 8 quarters
See the full check report
Quarterly results · Q2 2026
- Revenue639.5B KRW
- vs. year ago
- +10.4%
- vs. prior quarter
- +21.4%
- Operating income66.9B KRW
- vs. year ago
- +34.1%
- vs. prior quarter
- +658.6%
- Operating margin10.5%
- vs. year ago
- +1.8 pp
- vs. prior quarter
- +8.8 pp
Quarterly operating income trend
Same sector · 제약
Up +0.44%· 100 of 169 stocks up, preferred shares excluded · trading value 566.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +6.1% | Up +0.64% | 80.0B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -0.9% | Down -0.15% | 68.9B KRW |
| 파마리서치 | Close over the last 20 sessions -27.8% | Down -1.30% | 43.9B KRW |
| 한미약품 | Close over the last 20 sessions -27.1% | Up +5.42% | 42.3B KRW |
| 삼익제약 | Close over the last 20 sessions -13.1% | Up +9.54% | 34.5B KRW |
Other share classes of this company · 유한양행
Schedule
- Q3 report due · 11/16 (Mon) · in 18 days
- Next data 10/30 (Fri) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.